Microfluidic Drug Delivery System for Inner Ear
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drug delivery methods for inner ear disorders are inefficient and lack precise control, particularly for complex molecules, due to the blood-labyrinth barrier and anatomical challenges, leading to unpredictable drug distribution and significant side effects.
Innovation Solution
A microfluidic drug delivery system utilizing a recirculating stream of perilymph through a catheter, with a micropump and microvalves for controlled delivery of drugs directly to the cochlea, allowing for long-term, programmable, and sequenced delivery of multiple molecules with minimal side effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If systemic drug delivery is used to treat inner ear disorders, then drugs can reach the inner ear, but significant systemic side effects occur due to high doses required
Solution Approach 1:
The invention segments the drug delivery system into separate pathways: one for drug administration and another for fluid recirculation. The catheter is divided into multiple lumens that allow independent control of drug flow and perilymph flow, enabling localized drug delivery without systemic distribution
Solution Approach 2:
The recirculating perilymph acts as an intermediary carrier that transports drug molecules from the injection site throughout the inner ear fluid system. This mediator enables uniform drug distribution within the confined inner ear space without requiring high systemic doses
2Object-affected harmful factors
If transtympanic perfusion is used for drug delivery, then systemic side effects are reduced, but drug delivery to the inner ear is unpredictable due to anatomical barriers
Solution Approach 1:
The invention extracts the drug delivery process from the unpredictable transtympanic route and places it directly into the inner ear perilymphatic space. By injecting drugs directly into the perilymph through the cochlear catheter, the system bypasses the round window membrane and middle ear anatomical variations that cause unpredictable delivery
Solution Approach 2:
The recirculating pump system provides feedback control by continuously monitoring and adjusting the perilymph flow rate to maintain optimal drug distribution. The system can be programmed to deliver drugs at specific rates and intervals, ensuring predictable and reliable therapeutic concentrations
3Speed
If rapid drug delivery is used to achieve therapeutic concentrations, then treatment effectiveness is improved, but drug distribution becomes unpredictable and concentrated in certain areas
Solution Approach 1:
The invention implements continuous recirculating flow of perilymph through the cochlea and vestibule, ensuring that drug molecules are continuously distributed throughout the entire inner ear fluid system. This continuous action prevents localized concentration and ensures uniform therapeutic distribution
Solution Approach 2:
The system uses periodic pumping cycles to recirculate perilymph and drug molecules through the inner ear structures. The programmable pump delivers drugs in controlled intervals, allowing for both rapid initial delivery and subsequent distribution phases
4Quantity of substance
If complex molecules are delivered systemically, then they cannot cross the blood-labyrinth barrier, but delivery to the inner ear is blocked
Solution Approach 1:
The invention extracts complex drug molecules directly from the circulation and delivers them into the perilymphatic space, bypassing the blood-labyrinth barrier entirely. This direct injection method allows large proteins, peptides, and other complex molecules to reach their targets without needing to cross the protective barrier
Solution Approach 2:
The perilymph serves as an intermediary medium that receives complex molecules directly from injection and transports them to their targets within the inner ear. This intermediary pathway eliminates the need for the molecules to cross the blood-labyrinth barrier
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables precise and efficient delivery of drugs to the inner ear, reducing systemic side effects and maintaining therapeutic concentrations over extended periods, suitable for treating hearing loss and other inner ear disorders.
Implementation Method 1
a micropump and microvalves for controlled delivery of drugs directly to the cochlea
Implementation Method 2
a micropump and microvalves for controlled delivery of drugs
Data Source
Figure 1
Figure 2A~2B
Figure 3A
AI summary
An implantable drug delivery apparatus for delivering a drug into a bodily fluid in a bodily cavity of a patient over a period of time includes a drug supply reservoir (24) to supply drug into a delivery channel (1005) and an actuator for delivering the drug to a predetermined location in the bodily cavity of the patient, such as, for example, a cochlea of a human ear. The drug is loaded into the delivery channel while producing substantially negligible flow at an outlet (1010) of the delivery channel.